These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8458709)

  • 21. Drug firm suit fails to halt publication of Canadian Health Technology Report.
    Skolnick AA
    JAMA; 1998 Aug; 280(8):683-4. PubMed ID: 9728622
    [No Abstract]   [Full Text] [Related]  

  • 22. Canadian Coordinating Office for Health Technology Assessment.
    Menon D
    CMAJ; 1992 Jan; 146(2):113. PubMed ID: 1735034
    [No Abstract]   [Full Text] [Related]  

  • 23. Funding the new biologics--a health economic critique of the CCOHTA report: infliximab for the treatment of Crohn's disease.
    Mitton CR;
    Can J Gastroenterol; 2002 Dec; 16(12):873-6. PubMed ID: 12522479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health Technology Assessment International 7th Annual Meeting: Dublin, Ireland, 6–9 June 2010.
    Fogarty E; Tilson L; Ryan M; Barry M
    Expert Rev Pharmacoecon Outcomes Res; 2010 Oct; 10(5):501-3. PubMed ID: 20950064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Brazil participation on the IV Annual Meeting of Health Technology Assessment International in Barcelona Spain - 2007].
    Brasil. Ministério da Saúde. Departamento de Ciência e Tecnologia. Secretaria de Ciência e Tecnologia e Insumos Estratégicos
    Rev Saude Publica; 2007 Oct; 41(5):869-72. PubMed ID: 17923911
    [No Abstract]   [Full Text] [Related]  

  • 26. Health technology assessment: a European collaboration.
    Kaló Z; Vokó Z
    Expert Rev Pharmacoecon Outcomes Res; 2011 Feb; 11(1):41-3. PubMed ID: 21351855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The internationalization of health technology assessment.
    Menon D; Marshall D
    Int J Technol Assess Health Care; 1996; 12(1):45-51. PubMed ID: 8690561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reports from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). The efficacy of Tacrine and the measurement of outcomes of Alzheimer's disease.
    Int J Technol Assess Health Care; 1998; 14(2):398-9. PubMed ID: 9678977
    [No Abstract]   [Full Text] [Related]  

  • 29. The courts--a challenge to health technology assessment.
    Hemminki E; Hailey D; Koivusalo M
    Science; 1999 Jul; 285(5425):203-4. PubMed ID: 10428717
    [No Abstract]   [Full Text] [Related]  

  • 30. A Canadian perspective.
    Otten N
    Value Health; 1998 Nov; 1(4):218-23. PubMed ID: 16674543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. International meeting for HTA-emerging countries.
    Kahveci R
    Int J Technol Assess Health Care; 2009 Jul; 25(3):425-6. PubMed ID: 19619364
    [No Abstract]   [Full Text] [Related]  

  • 32. Joint project of the International Network of Agencies for Health Technology Assessment--Part 2: Managing the diffusion of positron emission tomography with health technology assessment.
    Adams EJ; Almazán C; Mørland B; Bradbury I; King R; Rheinberger P
    Int J Technol Assess Health Care; 2006; 22(2):149-54. PubMed ID: 16571189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Eighth International Conference on Smart Homes and Health Telematics 2010, July 22-24, 2010, Seoul, South Korea.
    Merrell RC
    Telemed J E Health; 2010 Oct; 16(8):920. PubMed ID: 20925571
    [No Abstract]   [Full Text] [Related]  

  • 34. Program and abstracts of the 8th annual meeting of the International Society for Heart Research--American Section, satellite symposium of the XXX International Physiological Congress, and the 3rd Annual Cardiology Symposium of the University of Manitoba. Winnipeg, Canada (July 8-11, 1986).
    J Mol Cell Cardiol; 1986 Jun; 18 Suppl 3():1-84. PubMed ID: 3723602
    [No Abstract]   [Full Text] [Related]  

  • 35. Navigating joint HTA, procurement, and fair pricing: evidence-based insights and practical recommendations - A meeting report from ISPOR regional conference in Warsaw, 2019.
    Inotai A; Németh B
    Expert Rev Pharmacoecon Outcomes Res; 2019 Aug; 19(4):379-381. PubMed ID: 31159614
    [No Abstract]   [Full Text] [Related]  

  • 36. Development of health technology assessment in Lithuania.
    Danguole J
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():140-2. PubMed ID: 19575824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals.
    Glennie JL; Torrance GW; Baladi JF; Berka C; Hubbard E; Menon D; Otten N; Rivière M
    Pharmacoeconomics; 1999 May; 15(5):459-68. PubMed ID: 10537963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eunethta: further steps towards European cooperation on health technology assessment.
    Guegan EW; Huić M; Teljeur C
    Int J Technol Assess Health Care; 2014 Nov; 30(5):475-7. PubMed ID: 25747555
    [No Abstract]   [Full Text] [Related]  

  • 39. [The health technology assessment].
    Corrao S; Arnone S; Sicurello F
    Recenti Prog Med; 2004 Nov; 95(11):529-34. PubMed ID: 15598091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The development of health care technology assessment. An international perspective.
    Battista RN; Hodge MJ
    Int J Technol Assess Health Care; 1995; 11(2):287-300. PubMed ID: 7790172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.